These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 21227614
1. MRI and PET/CT of patients with bone metastases from breast carcinoma. Grankvist J, Fisker R, Iyer V, Fründ ET, Simonsen C, Christensen T, Stenbygaard L, Ewertz M, Larsson EM. Eur J Radiol; 2012 Jan; 81(1):e13-8. PubMed ID: 21227614 [Abstract] [Full Text] [Related]
2. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases? Heusner T, Gölitz P, Hamami M, Eberhardt W, Esser S, Forsting M, Bockisch A, Antoch G. Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240 [Abstract] [Full Text] [Related]
3. Detection of bone metastases using diffusion weighted magnetic resonance imaging: comparison with (11)C-methionine PET and bone scintigraphy. Goudarzi B, Kishimoto R, Komatsu S, Ishikawa H, Yoshikawa K, Kandatsu S, Obata T. Magn Reson Imaging; 2010 Apr; 28(3):372-9. PubMed ID: 20106624 [Abstract] [Full Text] [Related]
4. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer. Pauls S, Schmidt SA, Juchems MS, Klass O, Luster M, Reske SN, Brambs HJ, Feuerlein S. Eur J Radiol; 2012 Jan; 81(1):178-82. PubMed ID: 20932700 [Abstract] [Full Text] [Related]
5. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer. Sakurai Y, Kawai H, Iwano S, Ito S, Ogawa H, Naganawa S. J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138 [Abstract] [Full Text] [Related]
6. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? Chen W, Jian W, Li HT, Li C, Zhang YK, Xie B, Zhou DQ, Dai YM, Lin Y, Lu M, Huang XQ, Xu CX, Chen L. Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042 [Abstract] [Full Text] [Related]
7. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT. van Ufford HM, Kwee TC, Beek FJ, van Leeuwen MS, Takahara T, Fijnheer R, Nievelstein RA, de Klerk JM. AJR Am J Roentgenol; 2011 Mar; 196(3):662-9. PubMed ID: 21343511 [Abstract] [Full Text] [Related]
8. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF. J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282 [Abstract] [Full Text] [Related]
9. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT. Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [Abstract] [Full Text] [Related]
10. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY. Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [Abstract] [Full Text] [Related]
15. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. Du Y, Cullum I, Illidge TM, Ell PJ. J Clin Oncol; 2007 Aug 10; 25(23):3440-7. PubMed ID: 17592153 [Abstract] [Full Text] [Related]
16. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R. Pediatr Blood Cancer; 2007 Dec 10; 49(7):901-5. PubMed ID: 17252575 [Abstract] [Full Text] [Related]
17. 18F-FDG PET/CT for staging of penile cancer. Scher B, Seitz M, Reiser M, Hungerhuber E, Hahn K, Tiling R, Herzog P, Reiser M, Schneede P, Dresel S. J Nucl Med; 2005 Sep 10; 46(9):1460-5. PubMed ID: 16157528 [Abstract] [Full Text] [Related]
18. In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit. Wild D, Eyrich GK, Ciernik IF, Stoeckli SJ, Schuknecht B, Goerres GW. J Craniomaxillofac Surg; 2006 Jan 10; 34(1):9-16. PubMed ID: 16343913 [Abstract] [Full Text] [Related]
19. Detection of metastatic bone lesions in breast cancer patients: fused (18)F-Fluoride-PET/MDCT has higher accuracy than MDCT. Preliminary experience. Piccardo A, Altrinetti V, Bacigalupo L, Puntoni M, Biscaldi E, Gozza A, Cabria M, Iacozzi M, Pasa A, Morbelli S, Villavecchia G, DeCensi A. Eur J Radiol; 2012 Oct 10; 81(10):2632-8. PubMed ID: 22227259 [Abstract] [Full Text] [Related]
20. Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy. Takano A, Oriuchi N, Tsushima Y, Taketomi-Takahashi A, Nakajima T, Arisaka Y, Higuchi T, Amanuma M, Endo K. Ann Nucl Med; 2008 Jun 10; 22(5):395-401. PubMed ID: 18600417 [Abstract] [Full Text] [Related] Page: [Next] [New Search]